| 408例缺血性脑血管病二级预防抗血小板药物应用状况调查 |
| |
| 引用本文： | 许明杰,马锐华,宋世萍,艾青,吕莹,王拥军.408例缺血性脑血管病二级预防抗血小板药物应用状况调查[J].中国实用神经疾病杂志,2009,12(1). |
| |
| 作者姓名： | 许明杰 马锐华 宋世萍 艾青 吕莹 王拥军 |
| |
| 作者单位： | 1. 北京市垂杨柳医院神经内科,北京,100022
2. 首都医科大学附属北京天坛医院神经内科,北京,100050 |
| |
| 摘 要： | 目的 了解北京市部分二级医院缺血性脑血管病二级预防抗血小板药物的应用现状,为改进缺血性脑血管病二级预防工作提供依据.方法 本研究为现况调查,研究对象为以自愿形式参加的北京市4家二级医院中急性脑梗死及短暂性脑缺血发作(TIA)的住院患者,调查其住院期间以及出院3个月二级预防抗血小板药物的应用现况.结果 人选患者共458例.其中408例完成3个月随访.住院期间抗血小板药物应用率为93.7%,3个月随访发现.抗血小板药物的院外治疗依从性差,应用率明显下降,为69.6%(P=0.003);男性(OR=1.708),95%CI 1.083～2.691及TIA患者(OR=1.954,95%CI1.046～3.649)成为患者抗血小板药物依从性差的促进因素.结论 北京市部分二级医院缺血性脑血管病二级预防抗血小板药物的应用现状不容乐观,临床医生应对缺血性脑血管病患者二级预防抗血小板药物的依从性给予关注.
|
| 关 键 词： | 动脉粥样硬化性脑梗死 抗血小板药物 |
The cross-sectional study on the status of antiplatelet in secondary prevention of 408 cases of cerebral ischemia patients |
| |
| Xu Mingjie,Ma Ruihua,Song Shiping,et al..The cross-sectional study on the status of antiplatelet in secondary prevention of 408 cases of cerebral ischemia patients[J].Chinese Journal of Practical Neruous Diseases,2009,12(1). |
| |
| Authors: | Xu Mingjie Ma Ruihua Song Shiping |
| |
| Institution: | Xu Mingjie,Ma Ruihua,Song Shiping,et al.Department of Neurology,Beijing Chuiyangliu Hospital,Beijing 100022,China |
| |
| Abstract: | Objective To investigate the status of the using of antiplatelet in secondary prevention of cerebral ischemia and to provide clues for improving the second prevention.Methods The study was a crosssectional investigation.All inpatients in diagnosis of acute cerebral infarction or TIA(transient ischemia attack) from four second class hospitals in Beijing were recruited.The status of the using of antiplatelet in secondary prevention of cerebral ischemia during hospitalization and at 3-month after discharging w... |
| |
| Keywords: | TIA |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
|
